Pharmaceutical News and Articles

FDA Approves Merck’s Welireg (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)

The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1

OSAKA, Japan and CAMBRIDGE, Massachusetts, May 14, 2025 Takeda (TSE 4502 NYSE TAK) today announced that the New England Journal of Medicine published data from

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

Pathological Fatigue Common Up to 12 Months After TIA

Pathological fatigue is common up to 12 months after a diagnosis of transient ischemic attack (TIA), according to a study published online May 14 in Neurology.

CDC: Drug Overdose Deaths Down More Than 25 Percent in 2024

Drug overdose deaths decreased by 26.9 percent from 2023 to 2024, according to provisional data released today from the National Center for Health Statistics. A

Multitarget Stool DNA Tests More Costly Than FIT for Colorectal Cancer Detection

Multitarget stool DNA test (MSDT)- and next-generation MSDT (N-G MSDT)-based screening have higher costs per detected advanced neoplasia case or early colorecta

Odds of Burnout Higher for Doctors Working With Incompletely Staffed Team

Working with an incompletely staffed team is associated with greater odds of burnout for physicians, according to a research letter published online May 14 in J

FDA Grants Accelerated Approval to Emrelis (telisotuzumab vedotin-tllv) for Non-Small Cell Lung Cancer With High c-Met Protein Overexpression

Ubrogepant (Ubrelvy) Effective Against Early Migraine Symptoms

Migraines don t just cause headaches. These attacks often are accompanied by symptoms like light and sound sensitivity, nausea, neck pain and dizziness. What s

FDA to Review and Possibly Ban Fluoride Supplements for Kids

WEDNESDAY, May 14, 2025 The U.S. Food and Drug Administration (FDA) plans to review and possibly remove prescription fluoride supplements for children from the